These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18068872)

  • 1. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS.
    Gijselinck I; Sleegers K; Engelborghs S; Robberecht W; Martin JJ; Vandenberghe R; Sciot R; Dermaut B; Goossens D; van der Zee J; De Pooter T; Del-Favero J; Santens P; De Jonghe P; De Deyn PP; Van Broeckhoven C; Cruts M
    Neurobiol Aging; 2009 Aug; 30(8):1329-31. PubMed ID: 18068872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
    Prudlo J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropathology of FTD associated With ALS.
    Mackenzie IR
    Alzheimer Dis Assoc Disord; 2007; 21(4):S44-9. PubMed ID: 18090423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease.
    Synofzik M; Born C; Rominger A; Lummel N; Schöls L; Biskup S; Schüle C; Grasshoff U; Klopstock T; Adamczyk C
    Neurobiol Aging; 2014 May; 35(5):1212.e1-5. PubMed ID: 24300238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of ALS and FTD: implications for translational studies.
    Liščić RM
    Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
    Barmada SJ; Finkbeiner S
    Rev Neurosci; 2010; 21(4):251-72. PubMed ID: 21086759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update.
    Lattante S; Rouleau GA; Kabashi E
    Hum Mutat; 2013 Jun; 34(6):812-26. PubMed ID: 23559573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
    Van Deerlin VM; Leverenz JB; Bekris LM; Bird TD; Yuan W; Elman LB; Clay D; Wood EM; Chen-Plotkin AS; Martinez-Lage M; Steinbart E; McCluskey L; Grossman M; Neumann M; Wu IL; Yang WS; Kalb R; Galasko DR; Montine TJ; Trojanowski JQ; Lee VM; Schellenberg GD; Yu CE
    Lancet Neurol; 2008 May; 7(5):409-16. PubMed ID: 18396105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amyotrophic lateral sclerosis and frontotemporal dementia: overlapping characteristics].
    Raaphorst J; Grupstra HF; Linssen WH; van Swieten JC; Schmand B; de Visser M
    Ned Tijdschr Geneeskd; 2010; 154():A631. PubMed ID: 20178658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel TARDBP mutations in Nordic ALS patients.
    Chiang HH; Andersen PM; Tysnes OB; Gredal O; Christensen PB; Graff C
    J Hum Genet; 2012 May; 57(5):316-9. PubMed ID: 22456481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The implications of TDP-43 mutations in pathogenesis of amyotrophic lateral sclerosis].
    Ishihara T; Yokoseki A; Nishizawa M; Takahashi H; Onodera O
    Brain Nerve; 2009 Nov; 61(11):1301-7. PubMed ID: 19938687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro.
    Winton MJ; Van Deerlin VM; Kwong LK; Yuan W; Wood EM; Yu CE; Schellenberg GD; Rademakers R; Caselli R; Karydas A; Trojanowski JQ; Miller BL; Lee VM
    FEBS Lett; 2008 Jun; 582(15):2252-6. PubMed ID: 18505686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis.
    Daoud H; Valdmanis PN; Kabashi E; Dion P; Dupré N; Camu W; Meininger V; Rouleau GA
    J Med Genet; 2009 Feb; 46(2):112-4. PubMed ID: 18931000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
    Verma A
    Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurodegenerative disorders and TDP-43].
    Nonaka T; Inukai Y; Arai T; Hasegawa M
    Brain Nerve; 2009 Feb; 61(2):161-6. PubMed ID: 19235466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel TARDBP missense mutation caused familial amyotrophic lateral sclerosis with frontotemporal dementia and parkinsonism.
    Chen S; Zhou RL; Zhang W; Che CH; Feng SY; Huang HP; Liu CY; Zou ZY
    Neurobiol Aging; 2021 Nov; 107():168-173. PubMed ID: 34175147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Bright F; Chan G; van Hummel A; Ittner LM; Ke YD
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel TARDBP insertion/deletion mutation in the flail arm variant of amyotrophic lateral sclerosis.
    Solski JA; Yang S; Nicholson GA; Luquin N; Williams KL; Fernando R; Pamphlett R; Blair IP
    Amyotroph Lateral Scler; 2012 Sep; 13(5):465-70. PubMed ID: 22424122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.